Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Vincent M. Coghlan is active.

Publication


Featured researches published by Vincent M. Coghlan.


Nature Structural & Molecular Biology | 1999

The molecular basis for protein kinase A anchoring revealed by solution NMR.

Marceen G. Newlon; Melinda Roy; Dimitrios Morikis; Zachary E. Hausken; Vincent M. Coghlan; John D. Scott; Patricia A. Jennings

Compartmentalization of signal transduction enzymes into signaling complexes is an important mechanism to ensure the specificity of intracellular events. Formation of these complexes is mediated by specialized protein motifs that participate in protein–protein interactions. The adenosine 3´,5´-cyclic monophosphate (cAMP)-dependent protein kinase (PKA) is localized through interaction of the regulatory (R) subunit dimer with A-kinase-anchoring proteins (AKAPs). We now report the solution structure of the type II PKA R-subunit fragment RIIα(1–44), which encompasses both the AKAP-binding and dimerization interfaces. This structure incorporates an X-type four-helix bundle dimerization motif with an extended hydrophobic face that is necessary for high-affinity AKAP binding. NMR data on the complex between RIIα(1–44) and an AKAP fragment reveals extensive contacts between the two proteins. Interestingly, this same dimerization motif is present in other signaling molecules, the S100 family. Therefore, the X-type four-helix bundle may represent a conserved fold for protein–protein interactions in signal transduction.


Journal of Biological Chemistry | 1996

Mutational Analysis of the A-Kinase Anchoring Protein (AKAP)-binding Site on RII CLASSIFICATION OF SIDE CHAIN DETERMINANTS FOR ANCHORING AND ISOFORM SELECTIVE ASSOCIATION WITH AKAPs

Zachary E. Hausken; Mark L. Dell'Acqua; Vincent M. Coghlan; John D. Scott

Compartmentalization of the type II cAMP-dependent protein kinase is conferred by interaction of the regulatory subunit (RII) with A-Kinase Anchoring Proteins (AKAPs). The AKAP-binding site involves amino-terminal residues on each RII protomer and is formed through dimerization. A site-directed mutagenesis strategy was utilized to assess the contribution of individual residues in either RII isoform, RIIα or RIIβ, for interaction with various anchoring proteins. Substitution of long-chain or bulky hydrophobic groups (leucines or phenylalanines) for isoleucines at positions 3 and 5 in RIIα decreased AKAP-binding up to 24 ± 3 (n = 8)-fold, whereas introduction of valines had minimal effects. Replacement with hydrophilic residues (serine or asparigine) at both positions abolished AKAP binding. Mutation of proline 6 in RIIα reduced binding for four AKAPs (Ht31, MAP2, AKAP79, and AKAP95) from 2.3 to 20-fold (n = 4) whereas introduction of an additional proline at position 6 in RIIβ increased or conferred binding toward these anchoring proteins. Therefore, we conclude that β-branched side chains at positions 3 and 5 are favored determinants for AKAP-binding and prolines at positions 6 and 7 increase or stabilize RIIα interaction with selected anchoring proteins.


Molecular and Cellular Biochemistry | 1993

A-Kinase Anchoring Proteins

Vincent M. Coghlan; Susan E. Bergeson; Lorene K. Langeberg; Gajanan Nilaver; John D. Scott

The cAMP-dependent protein kinase (PKA) regulates a variety of diverse biochemical events through the phosphorylation of target proteins. Because PKA is a multifunctional enzyme with a broad substrate specificity, its compartmentalization may be a key regulatory event in controlling which particular target substrates are phosphorylated. In recent years it has been demonstrated that differential localization of the type II holoenzyme is directed through interaction of the regulatory subunit (RII) with a family ofA-KinaseAnchoringProteins (AKAPs). In this report, we review evidence for PKA compartmentalization and discuss the structural and functional properties of AKAPs.


Neuromolecular Medicine | 2005

Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.

Jonathan A. Sayer; Maria Manczak; Lakshmi Akileswaran; P. Hemachandra Reddy; Vincent M. Coghlan

Although expansion of a polyglutamine tract in the huntingtin protein is known to cause Huntington’s disease (HD), there is considerable debate as to how this mutation leads to the selective neuronal loss that characterizes the disease. The observation that mutant huntingtin accumulates in neuronal nuclei has led to the hypothesis that the molecular mechanism may involve the disruption of specific nuclear activities. Recently, several nuclear interaction partners for huntingtin have been identified, including HypA, a splicing factor-like protein of unknown function. Using a yeast two-hybrid screen, we have identified the interaction of HypA with the nuclear scaffold protein NAKAP. Interaction of NAKAP with HypA is specific and occurs both in yeast and in vitro. Deletion-mapping studies indicate that binding occurs via a proline-rich domain in NAKAP with a WW domain of HypA. In cultured cells, NAKAP and HypA localize within the nucleus and copurify with the nuclear matrix. Furthermore, NAKAP associates with HypA from human brain and copurifies with huntingtin protein in brain tissue obtained from HD patients. In HD neurons, NAKAP and mutant huntingtin were colocalized to the nuclear matrix and were found to be components of nuclear aggregates. Hence, the NAKAP-HypA scaffold is a potential nuclear docking site for huntingtin protein and may contribute to the nuclear accumulation of huntingtin observed in HD.


Science | 1995

Association of protein kinase A and protein phosphatase 2B with a common anchoring protein

Vincent M. Coghlan; Ba Perrino; M Howard; Lorene K. Langeberg; James Hicks; Wm Gallatin; John D. Scott


Journal of Biological Chemistry | 1994

TYPE II REGULATORY SUBUNIT (RII) OF THE CAMP-DEPENDENT PROTEIN KINASE INTERACTION WITH A-KINASE ANCHOR PROTEINS REQUIRES ISOLEUCINES 3 AND 5

Zachary E. Hausken; Vincent M. Coghlan; Cheryl A. Schafer Hastings; Erwin M. Reimann; John D. Scott


Journal of Biological Chemistry | 1994

Cloning and characterization of AKAP 95, a nuclear protein that associates with the regulatory subunit of type II cAMP-dependent protein kinase

Vincent M. Coghlan; Lorene K. Langeberg; Anne Fernandez; Ned Lamb; John D. Scott


Journal of Biological Chemistry | 1996

Cloning and Characterization of a Novel A-kinase Anchoring Protein AKAP 220, ASSOCIATION WITH TESTICULAR PEROXISOMES

Linda B. Lester; Vincent M. Coghlan; Brian Nauert; John D. Scott


Journal of Biological Chemistry | 2001

A-kinase-anchoring Protein AKAP95 Is Targeted to the Nuclear Matrix and Associates with p68 RNA Helicase

Lakshmi Akileswaran; Justin W. Taraska; Jonathan A. Sayer; Jessica M. Gettemy; Vincent M. Coghlan


American Journal of Physiology-renal Physiology | 2001

AQP2 is a substrate for endogenous PP2B activity within an inner medullary AKAP-signaling complex

Inho Jo; Donald T. Ward; Michelle A. Baum; John D. Scott; Vincent M. Coghlan; Timothy G. Hammond; H. William Harris

Collaboration


Dive into the Vincent M. Coghlan's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michelle A. Baum

Boston Children's Hospital

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge